Research and Development
Imaging Equipment Limited (IEL) is committed to supporting both medical research and product development in the UK. This is achieved through collaboration with UK Universities and medical equipment manufacturers worldwide and recent projects include;
The following presentations were acknowledged as being supported with IEL Research Funds.
British Nuclear Medicine Society, Brighton, May 2011
Nawaz S, Berry DJ, Ballinger JR, Blower PJ.
A tripodal hexadentae chelator for gallium-68: comparison with other chelators which label at room temperature
Ballinger JR, Nawaz S, Berry DJ, Blower PJ.
Monitoring the performance characteristics of the IGG100 gallium-68 generator
Ballinger JR.
Practicalities of using the gallium-68 generator
King's College University - where researchers are trying to develop a highly specific peptide or protein which will be used as a radiotracer in PET imaging and possibly in radioisotope therapy. IEL is committed to the concept of patient stratification, where the diagnosis and treatment of patients is increasingly based on treating each patient as an individual rather than assuming that patients will respond equally to diagnostic and therapeutic medical interventions.
University of Sussex Medical Imaging Centre - IEL are collaborating in the development of a spinout company called 'TexRAD Limited', which will commercialise a novel algorithm based software to help oncologists and radiologists differentiate between high risk cancer and provide rapid feedback on patients' response to chemotherapy.
IEL has also worked with a major radiotherapy equipment manufacturer to build a dynamic imaging phantom which simulates human breathing during radiotherapy, enabling radiation dosimetrists to plan effective lung treatments.
IEL is a major shareholder in a specialist medical imaging company called 'Prostate Mapping Limited' which develops new and effective imaging techniques for diagnosis and correct risk stratification of men with prostate cancer.
